EUVIMED · CrossrefJournal
Molecular Cancer
ISSN 1476-4598 · Springer Science and Business Media LLC
Frequent topics
HIC1promoter hypermethylationBRCA1DNA methylationMGMTRASSF1Acervical cancerepigenetic silencinghistone deacetylase inhibitorstesticular germ cell tumorstumor suppressorBrn2
Latest articles
Optimized organoid culture protocol for primary non-small cell lung cancer and predicting individual drug response
Disruption of NUAK2‑Mediated RNA splicing by trilaciclib reveals a therapeutic vulnerability in AR‑Indifferent prostate cancer
Antibody–drug conjugates combined with immune checkpoint inhibitors in cancer: mechanisms, clinical evidence, and translational challenges
Lactate metabolism and epigenetic reprogramming in cancer: beyond energy metabolism to chromatin dynamics
Lactate and lactylation in cancer: mechanistic insights and therapeutic implications
From molecular bridges to therapeutic targets: the pivotal role of liquid-liquid phase separation in tumors and new frontiers in targeted therapy
The evolution of “magic bullets”: precision guidance, clinical challenges, and efficacy enhancement of antibody-drug conjugates in solid tumors
Correction: Novel humanized monoclonal antibodies against ROR1 for cancer therapy
Hippo pathway in cancer immunity: tumor microenvironment remodeling, immune evasion, and therapeutic targeting
Pyroptosis-metabolism crosstalk: rewiring tumor pathogenesis for precision therapeutic breakthroughs
Polystyrene nanoplastics promote colorectal tumorigenesis via gut microbiota-metabolite-Th17 cell axis
Radioresistance and tumor recurrence: cellular plasticity, tolerant niches, and therapeutic opportunities
Interconnected death: crosstalk among ferroptosis, cuproptosis, and pyroptosis in cancer
Mechanosensitive epitranscriptomics in cancer: linking tumor mechanics, RNA modification, and immune escape
The abscopal effect and systemic immune reprogramming: from phenomenon to therapeutic design
IGF2BP3 promotes M2 macrophage polarization and ESCC progression by increasing USP36-mediated β-catenin stabilization
siRNA-mediated mismatch repair disruption synergizes with oxaliplatin to restore immune surveillance in microsatellite-stable colorectal cancer
The intratumoral microbiome as an emerging hub in cancer pathogenesis and precision oncology
Evolutionary insights into tumor progression: integrating genetic mutations and phenotypic plasticity
Programmable ZBTB7A RNA N6-methyladenosine site-specific demethylation suppresses colorectal cancer liver metastasis
The bright side of the stroma: the tumor-suppressive roles of cancer-associated fibroblasts
Editorial expression of concern: Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer
CRISPR screens reveal MCT1-driven metabolic escape from SMAD3 inhibition as a therapeutic vulnerability
T cell exhaustion in cancer: from functional decline to adaptive immune regulation
The influence of hypoxia on cancer lipid metabolism: a scoping review
Ubiquitination in cancer: mechanisms, signaling networks and potential therapeutic opportunities
MINK1 inhibition suppresses triple-negative breast cancer by abrogating ALDOA S39 phosphorylation and reprogramming glucose metabolism
The serotonin axis in cancer: metabolism, epigenetics, and immune regulation
Non-histone protein L-lactylation in cancer: a metabolic switch for immune evasion and therapeutic resistance
Alternative polyadenylation in cancer: mechanisms, functions, and therapeutic potential
EUVIMED